- Home
- FTI vs ASND Comparison
FTI vs ASND Comparison
Compare FTI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- ASND
- Stock Information
- Founded
- FTI 1884
- ASND 2006
- Country
- FTI United States
- ASND Denmark
- Employees
- FTI N/A
- ASND N/A
- Industry
- FTI Metal Fabrications
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- FTI Industrials
- ASND Health Care
- Exchange
- FTI Nasdaq
- ASND Nasdaq
- Market Cap
- FTI 10.9B
- ASND 9.1B
- IPO Year
- FTI N/A
- ASND 2015
- Fundamental
- Price
- FTI $29.87
- ASND $151.25
- Analyst Decision
- FTI Strong Buy
- ASND Strong Buy
- Analyst Count
- FTI 13
- ASND 16
- Target Price
- FTI $36.33
- ASND $213.88
- AVG Volume (30 Days)
- FTI 4.5M
- ASND 564.4K
- Earning Date
- FTI 04-24-2025
- ASND 05-01-2025
- Dividend Yield
- FTI 0.67%
- ASND N/A
- EPS Growth
- FTI 393.36
- ASND N/A
- EPS
- FTI 1.96
- ASND N/A
- Revenue
- FTI $9,295,000,000.00
- ASND $398,509,511.00
- Revenue This Year
- FTI $9.16
- ASND $62.61
- Revenue Next Year
- FTI $6.51
- ASND $72.16
- P/E Ratio
- FTI $15.26
- ASND N/A
- Revenue Growth
- FTI 14.03
- ASND 12.06
- 52 Week Low
- FTI $22.12
- ASND $111.09
- 52 Week High
- FTI $33.45
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- FTI 60.30
- ASND 41.32
- Support Level
- FTI $28.91
- ASND $164.24
- Resistance Level
- FTI $29.73
- ASND $183.00
- Average True Range (ATR)
- FTI 0.89
- ASND 7.88
- MACD
- FTI 0.36
- ASND -1.35
- Stochastic Oscillator
- FTI 91.75
- ASND 0.44
About FTI TechnipFMC plc
TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.